Bioceres Crop Solutions Corp. (NASDAQ:BIOX – Get Free Report) was the recipient of a significant decrease in short interest in the month of January. As of January 15th, there was short interest totalling 584,300 shares, a decrease of 18.6% from the December 31st total of 717,500 shares. Approximately 1.8% of the shares of the company are short sold. Based on an average trading volume of 199,600 shares, the days-to-cover ratio is presently 2.9 days.
Bioceres Crop Solutions Stock Down 4.4 %
NASDAQ BIOX traded down $0.30 during mid-day trading on Monday, reaching $6.55. 100,464 shares of the company’s stock traded hands, compared to its average volume of 204,094. The company has a market cap of $410.75 million, a price-to-earnings ratio of 327.66 and a beta of 0.57. The company has a fifty day simple moving average of $6.69 and a 200-day simple moving average of $7.95. The company has a current ratio of 1.27, a quick ratio of 0.87 and a debt-to-equity ratio of 0.37. Bioceres Crop Solutions has a 1-year low of $5.71 and a 1-year high of $14.05.
Bioceres Crop Solutions (NASDAQ:BIOX – Get Free Report) last issued its quarterly earnings data on Monday, November 11th. The company reported ($0.09) earnings per share for the quarter, missing the consensus estimate of $0.02 by ($0.11). The firm had revenue of $92.60 million during the quarter, compared to the consensus estimate of $117.15 million. Bioceres Crop Solutions had a net margin of 0.53% and a return on equity of 0.68%. During the same quarter in the prior year, the business earned ($0.07) earnings per share. As a group, equities research analysts expect that Bioceres Crop Solutions will post 0.12 EPS for the current year.
Institutional Trading of Bioceres Crop Solutions
Analysts Set New Price Targets
A number of brokerages recently commented on BIOX. Canaccord Genuity Group reduced their price objective on Bioceres Crop Solutions from $10.00 to $9.50 and set a “buy” rating on the stock in a research report on Wednesday, November 13th. Oppenheimer dropped their target price on Bioceres Crop Solutions from $13.00 to $12.00 and set an “outperform” rating for the company in a research report on Tuesday, January 28th. Four research analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Buy” and an average price target of $11.88.
View Our Latest Stock Analysis on Bioceres Crop Solutions
Bioceres Crop Solutions Company Profile
Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.
Featured Stories
- Five stocks we like better than Bioceres Crop Solutions
- Quiet Period Expirations Explained
- How to Invest in Small Cap Stocks
- Financial Services Stocks Investing
- These Are the Dividend Stocks Insiders Bought in January
- How to Use Stock Screeners to Find Stocks
- How the ‘No Buy’ Trend of 2025 Is Boosting These 3 Stocks
Receive News & Ratings for Bioceres Crop Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioceres Crop Solutions and related companies with MarketBeat.com's FREE daily email newsletter.